Rare diseases
Investigational molecules
Locations
Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
HungaryA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
HungaryA study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis
HungaryA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
HungaryEfficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
HungaryEvaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
HungaryA study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese
HungaryTesting Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned
HungaryA study testing aprepitant gel for treating skin rash in cancer patients receiving epidermal growth factor receptor inhibitor therapy
HungaryA Study Testing Imeroprubart for Adults with Primary Sjogren's Disease with Moderate to Severe Symptoms
HungaryA study to test if tibulizumab works and is safe for adults with systemic sclerosis
HungaryA Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity
HungaryTell us about your condition – we search every trial in Europe and connect you with the right site.
